{"batchcomplete":"","continue":{"lecontinue":"20260216190922|571","continue":"-||"},"query":{"logevents":[{"logid":581,"ns":10,"title":"Vorlage:ChatGPT","pageid":536,"logpage":536,"revid":1066,"params":{},"type":"create","action":"create","user":"Andrea.F","timestamp":"2026-02-17T22:40:19Z","comment":"Die Seite wurde neu angelegt: \u201e{| class=\"toccolours\" align=\"center\" width=\"60%\" | align=\"center\"| [[Bild:Wikkilogo.png|50px|Diser Artikel ist unvollst\u00e4ndig]] | '''Hinweis''': Dieser Artikel wurde von  mit Hilfe ChatGPT generiert. Der Inhalt wurde \u00dcberpr\u00fcft. |}    [[Kategorie:Vorlagen]]\u201c"},{"logid":580,"ns":0,"title":"Hauptseite","pageid":1,"logpage":1,"revid":1065,"params":{"description":"\u200e[edit=sysop] (unbeschr\u00e4nkt)\u200e[move=sysop] (unbeschr\u00e4nkt)","details":[{"type":"edit","level":"sysop","expiry":"infinite"},{"type":"move","level":"sysop","expiry":"infinite"}]},"type":"protect","action":"protect","user":"Andrea.F","timestamp":"2026-02-17T22:25:34Z","comment":""},{"logid":579,"ns":0,"title":"Mepolizumab","pageid":535,"logpage":535,"revid":1063,"params":{},"type":"create","action":"create","user":"Andrea.F","timestamp":"2026-02-17T16:24:44Z","comment":"Die Seite wurde neu angelegt: \u201eMepolizumab (Handelsname Nucala) hat k\u00fcrzlich wichtige Zulassungen als Biologikum zur Behandlung der COPD erhalten, sofern ein eosinophiler Ph\u00e4notyp vorliegt.  Aktueller Zulassungsstatus (Februar 2026)  Europ\u00e4ische Union: Die Europ\u00e4ische Kommission hat Mepolizumab am 6. Februar 2026 als Zusatztherapie f\u00fcr Erwachsene mit unkontrollierter COPD und erh\u00f6hten Eosinophilen-Werten zugelassen. USA: Die FDA erteilte die Zulassung bereits im Mai 2025 Gro\u00dfbri\u2026\u201c"},{"logid":578,"ns":6,"title":"Datei:Eflow-rapid.jpg","pageid":534,"logpage":534,"revid":1062,"params":{},"type":"create","action":"create","user":"Andrea.F","timestamp":"2026-02-16T19:13:06Z","comment":""},{"logid":577,"ns":6,"title":"Datei:Eflow-rapid.jpg","pageid":534,"logpage":534,"revid":1062,"params":{"img_sha1":"fxscvnw5b83iy56674blg83vsykmobn","img_timestamp":"2026-02-16T19:13:06Z"},"type":"upload","action":"upload","user":"Andrea.F","timestamp":"2026-02-16T19:13:06Z","comment":""},{"logid":576,"ns":6,"title":"Datei:Theraband2.jpg","pageid":533,"logpage":533,"revid":1061,"params":{},"type":"create","action":"create","user":"Andrea.F","timestamp":"2026-02-16T19:11:39Z","comment":""},{"logid":575,"ns":6,"title":"Datei:Theraband2.jpg","pageid":533,"logpage":533,"revid":1061,"params":{"img_sha1":"eiv7avd1urzuoflhusjablm4npw4spu","img_timestamp":"2026-02-16T19:11:39Z"},"type":"upload","action":"upload","user":"Andrea.F","timestamp":"2026-02-16T19:11:39Z","comment":""},{"logid":574,"ns":6,"title":"Datei:Bodyfit.jpg","pageid":532,"logpage":532,"revid":1060,"params":{},"type":"create","action":"create","user":"Andrea.F","timestamp":"2026-02-16T19:10:49Z","comment":""},{"logid":573,"ns":6,"title":"Datei:Bodyfit.jpg","pageid":532,"logpage":532,"revid":1060,"params":{"img_sha1":"nmdnaixtoesrr7812szb6rmmwh35j4v","img_timestamp":"2026-02-16T19:10:49Z"},"type":"upload","action":"upload","user":"Andrea.F","timestamp":"2026-02-16T19:10:49Z","comment":""},{"logid":572,"ns":6,"title":"Datei:Minitrainer1.jpg","pageid":531,"logpage":531,"revid":1058,"params":{},"type":"create","action":"create","user":"Andrea.F","timestamp":"2026-02-16T19:09:22Z","comment":""}]}}